Dergiler / Turkish Journal of Medical Sciences / 2007 / Cilt: 37 - Sayı: 1

Iki lokal anesteziğin antibakteriyal etkilerinin karşılaştırılması:Lidokain ve artikain

Comparison of the antibacterial effect of two local anesthetics:Liddocaine and articaine

Sayfa
7–10
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusions: The finding of articaine’s bacteriostatic effect against all bacterial strains might be an evidence for its antibacterial use.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: The antibacterial effect of lidocaine has been studied widely, but the effect of articaine has not yet been evaluated.
📊
Temel Bulgular & Veri:Materials and Methods: The antibacterial effects of articaine and lidocaine were studied on Pseudomonas aeruginosa ATCC27853, Staphylococcus aureus ATCC25923, Escherichia coli ATCC35218, and Proteus mirabilis ATCC7002 strains and a patient isolate of Serratia marcescens.
💡
Sonuç & Katkı:Conclusions: The finding of articaine’s bacteriostatic effect against all bacterial strains might be an evidence for its antibacterial use.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Aim: The antibacterial effect of lidocaine has been studied widely, but the effect of articaine has not yet been evaluated. We aimed to investigate whether commercially available articaine possesses bactericidal or bacteriostatic effect in comparison with lidocaine in a prospective laboratory setting. Materials and Methods: The antibacterial effects of articaine and lidocaine were studied on Pseudomonas aeruginosa ATCC27853, Staphylococcus aureus ATCC25923, Escherichia coli ATCC35218, and Proteus mirabilis ATCC7002 strains and a patient isolate of Serratia marcescens. For this study, 2% lidocaine HCl and articaine HCl were diluted to 10, 5, 2.5, 1.25, 0.625, 0.312, 0.156, and 0.078 mg ml-1 concentrations to determine the antibacterial effect. All bacterial strains were inoculated to 2 ml antibiotic broth at a concentration of 5X105 m-1 for each well. For each bacterial strain, minimal bactericidal concentration (MBC) was evaluated by inoculating the content of wells onto blood agar plates and incubating for 24 hours. Results: MBC was detected for both of the local anesthetics. Although articaine showed bacteriostatic effect on all bacterial strains, two of five strains were resistant to lidocaine. Conclusions: The finding of articaine’s bacteriostatic effect against all bacterial strains might be an evidence for its antibacterial use.

Abstract

Aim: The antibacterial effect of lidocaine has been studied widely, but the effect of articaine has not yet been evaluated. We aimed to investigate whether commercially available articaine possesses bactericidal or bacteriostatic effect in comparison with lidocaine in a prospective laboratory setting. Materials and Methods: The antibacterial effects of articaine and lidocaine were studied on Pseudomonas aeruginosa ATCC27853, Staphylococcus aureus ATCC25923, Escherichia coli ATCC35218, and Proteus mirabilis ATCC7002 strains and a patient isolate of Serratia marcescens. For this study, 2% lidocaine HCl and articaine HCl were diluted to 10, 5, 2.5, 1.25, 0.625, 0.312, 0.156, and 0.078 mg ml-1 concentrations to determine the antibacterial effect. All bacterial strains were inoculated to 2 ml antibiotic broth at a concentration of 5X105 m-1 for each well. For each bacterial strain, minimal bactericidal concentration (MBC) was evaluated by inoculating the content of wells onto blood agar plates and incubating for 24 hours. Results: MBC was detected for both of the local anesthetics. Although articaine showed bacteriostatic effect on all bacterial strains, two of five strains were resistant to lidocaine. Conclusions: The finding of articaine’s bacteriostatic effect against all bacterial strains might be an evidence for its antibacterial use.

🔖

Bu Makaleye Atıf Yap

DOĞAN, B., GÜNAYDIN, B., ROTA, S., KÖKTEN, G., BOZDAYI, G., KAYA, K. (2022). Iki lokal anesteziğin antibakteriyal etkilerinin karşılaştırılması:Lidokain ve artikain. Turkish Journal of Medical Sciences, Cilt: 37 - Sayı: 1, 7–10. https://ajindex.com/articles/611828

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Urmey WF. Spinal anaesthesia for outpatient surgery. Best Pract Res Clin Anaesthesiol 2003; 17: 335-346
  2. Chelly JE, Gebhard R, Greger J, Al Samsam T. Regional anesthesia for outpatient orthopedic surgery. Minerva Anestesiol 2001; 67(9 Suppl 1): 227-232
  3. Oertel R, Richter K, Weile K, Gramatte T, Berndt A, Feller K. A simple method for the determination of articaine and its metabolite articainic acid in dentistry: application to a comparison of articaine and lidocaine concentrations in alveolus blood. Methods Find Exp Clin Pharmacol 1993; 15: 541-547
  4. Simon MAM, Gielen MJM, Alberink N, Vree TB, Van Egmond J. Intravenous regional anesthesia with 0.5% articaine, 0.5% lidocaine, or 0.5% prilocaine. Reg Anesth 1997; 22: 29-34
  5. Oertel R, Rahn R, Kirch W. Clinical pharmacokinetics of articaine. Clin Pharmacokinet 1997; 33: 417-425
  6. Kallio H, Snall EV, Luode T, Rosenberg PH. Hyperbaric articaine for day-case spinal anaesthesia. Br J Anaesth 2006; 97: 704-709
  7. Kaya K, Akcabay M, Rota S, Karsligil T, Boyaci I, Yardim S. Does ketamine have antibacterial effect? Gazi Med J 1993; 2: 73-75
  8. Hirota K, Lambert DG. Ketamine: its mechanism of action and unusual clinical uses. Br J Anaesth 1996; 77: 441-444
  9. Gajraj RJ, Hodson MJ, Gillespie JA, Kenny GNC, Scott NB. Antibacterial activity of lidocaine in mixtures with Diprivan. Br J Anaesth 1998; 81: 444-448
  10. Pere P, Lindgren L, Vaara M. Poor antibacterial effect of ropivacaine. Comparison with bupivacaine. Anesthesiology 1999; 91: 884-886
  11. Aydin ON, Eyigor M, Aydin N. Antimicrobial activity of ropivacaine and other local anaesthetics. Eur J Anaesthesiol 2001; 18: 687- 12. Rota S, Akçabay M, Emektafl G, Boyac› I, Tokgöz D, Kaya K. Antibacterial activity of bupivacaine. Gazi Med J 1993; 2: 69-71
  12. Cook TM, James PA, Stannard CF. Diamorphine and bupivacaine mixtures: an in vitro study of microbiological safety. Pain 1998; 76: 259-263
  13. National Committee for Clinical and Laboratory Standards (NCCLS) Institute. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth International Supplement. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, 2005
  14. Thompson KD, Welykyj S, Massa MC. Antibacterial activity of lidocaine in combination with a bicarbonate buffer. J Dermatol Surg Oncol 1993; 19: 216-220
  15. Olsen KM, Peddicord TE, Campbell GD, Rupp ME. Antimicrobial effects of lidocaine in bronchoalveolar lavage fluid. J Antimicrobiol Chem 2000; 45: 217-219. 1